By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Samsung spinoff wins FDA clearance for AI ECG analysis software
    By
    msadmin
    October 11, 2026
    FDA clears software that builds 3D bone from a routine spine MRI
    By
    msadmin
    October 11, 2026
    Vitalize raises $31M to run hospitals like air traffic control
    By
    msadmin
    October 11, 2026
    Healthleap nets $38M to catch what hospital charts hide
    By
    msadmin
    October 11, 2026
    A robotics upstart banks $75M to build drugs without hands
    By
    msadmin
    October 11, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

AAMI Adopts National Academy of Medicine’s AI Code of Conduct to Guide Ethical Use in Medical Devices

The efforts align with the NAM’s AI Code of Conduct to support ethical, equitable, and effective AI integration in health technology.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Published: July 3, 2025
Share
3 Min Read
SHARE

As first reported by GlobeNewswire, the Association for the Advancement of Medical Instrumentation (AAMI) has announced its formal alignment with the National Academy of Medicine’s (NAM) newly released AI Code of Conduct for Health and Medicine. This 189-page document lays out six foundational commitments for the ethical development and deployment of artificial intelligence in the medical field. AAMI plans to leverage the Code across its standards-setting, education, and certification work to ensure AI in medical devices is safe, effective, and equitable.

Contents
Six commitments guiding responsible AISupporting standards and sector-wide adoptionCollaborative effort led by industry leaders

Source: x.com/theNAMedicine.

Six commitments guiding responsible AI

The Code of Conduct emphasizes six guiding principles: Advance Humanity, Ensure Equity, Engage Impacted Individuals, Improve Workforce Well-Being, Monitor Performance, and Innovate and Learn. These commitments serve as a practical framework for evaluating AI technologies across the healthcare sector. AAMI’s Chief Learning and Development Officer, Robert Burroughs, noted the Code’s potential to unify and inform AAMI’s efforts, offering members and stakeholders a shared ethical foundation as AI becomes increasingly central to medical device innovation.

Supporting standards and sector-wide adoption

AAMI Vice President of Standards, Matt Williams, highlighted the Code’s utility in supporting the development of regulatory-ready guidance documents, especially as AAMI committees address the fast-evolving AI landscape. The organization also plans to produce an executive summary of the AICC later this year to make the 189-page document more accessible. To further facilitate adoption, NAM’s Senior Advisor Laura Adams authored a companion guide titled Why and How to Use the NAM AICC, aimed at helping organizations navigate and apply the Code effectively.

Collaborative effort led by industry leaders

The AICC was the result of a robust, expert-driven review process that included contributions from leading figures in the field, such as Bakul Patel, Google’s Senior Director of Global Digital Health Strategy and AAMI board member, and Pat Baird, Regulatory Head of Global Software Standards at Philips. Their involvement, alongside AAMI leadership like Timothy Hsu, reflects a collaborative approach to establishing meaningful and practical AI governance in healthcare.

With its adoption of the NAM AI Code of Conduct, AAMI is taking a proactive role in shaping the ethical integration of AI in medical technology. By aligning with a clear and actionable framework, the organization reinforces its commitment to safety, innovation, and equity in a field where the responsible use of AI is critical to public trust and clinical impact.

VIA:GlobalNewswire
Share This Article
Facebook Copy Link Print
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.

You Might Also Like

News & Alerts

Tsinghua AI eye clinic shows what AI-native care still needs

By
msadmin
September 13, 2026
News & Alerts

Inspiren lands $70M as senior living operators adopt room sensors

By
msadmin
September 12, 2026
News & Alerts

Cradle signs a drug discovery deal with Hansa Biopharma

By
msadmin
October 2, 2026
News & Alerts

Carotid plaque AI flags stroke risk in under a second

By
msadmin
October 10, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal